Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Clinical trial NCT00086112 · COMPLETED
Trial details
- NCT number
- NCT00086112
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.